Loading…
Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers
Methicillin-resistant Staphylococcus aureus (MRSA) is globally endemic and is a leading cause of surgical site infection (SSI). The purpose of this study was to evaluate the incidence of SSI in MRSA carriers undergoing elective hip or knee arthroplasty, who had confirmed eradication and to compare i...
Saved in:
Published in: | The Journal of arthroplasty 2017-12, Vol.32 (12), p.3711-3717 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c356t-a507c44982e536efdc6b6a57753ea31906fe5f4c774cc7965d6430e8caf80b0f3 |
---|---|
cites | cdi_FETCH-LOGICAL-c356t-a507c44982e536efdc6b6a57753ea31906fe5f4c774cc7965d6430e8caf80b0f3 |
container_end_page | 3717 |
container_issue | 12 |
container_start_page | 3711 |
container_title | The Journal of arthroplasty |
container_volume | 32 |
creator | Tandon, Tarang Tadros, Baha J. Akehurst, Harold Avasthi, Adhish Hill, Richard Rao, Madhu |
description | Methicillin-resistant Staphylococcus aureus (MRSA) is globally endemic and is a leading cause of surgical site infection (SSI). The purpose of this study was to evaluate the incidence of SSI in MRSA carriers undergoing elective hip or knee arthroplasty, who had confirmed eradication and to compare it with incidence of SSI in non-MRSA carriers.
This is a retrospective analysis of 6613 patients who underwent elective total hip arthroplasty (THA; n = 3347) and total knee arthroplasty (TKA; n = 3266) at our institution. A cohort of patients who were preoperatively colonized with MRSA was identified. We compared the infection rates with non-MRSA carriers.
We had a colonization rate of 1.3% (83 patients). A total of 79 patients had confirmed eradication of carrier status before surgical intervention. Of these, 38 were THAs and 41 were TKAs. Five of 79 patients (6.32%; 95% confidence interval [CI]: 2.35%-14.79%) had “deep SSI” within 1 year of surgery. There were 2 MRSA infections in THAs (relative risk 4.46; 95% CI: 1.12-17.82). There were 2 MRSA and 1 methicillin-sensitive Staphylococcus aureus infections in TKAs (relative risk 5.61; 95% CI: 1.81-17.38). A significant statistical difference in infection rates from MRSA negative control group was noted, which had a deep sepsis rate of 1.17% in THAs and 1.3% in TKAs over the same period.
In spite of a selective treatment program for carriers and confirmed eradication, there is still a significantly increased risk of SSI in MRSA-colonized patients undergoing hip or knee arthroplasties. |
doi_str_mv | 10.1016/j.arth.2017.06.036 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1923112443</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S088354031730565X</els_id><sourcerecordid>1923112443</sourcerecordid><originalsourceid>FETCH-LOGICAL-c356t-a507c44982e536efdc6b6a57753ea31906fe5f4c774cc7965d6430e8caf80b0f3</originalsourceid><addsrcrecordid>eNp9kE1v1DAURS0EokPhD7BAXrJJ-hx_JJHYjKIprVpUaaasLY_zTD1knMHOVGLR_47DFJZdvbe490j3EPKRQcmAqYtdaeL0UFbA6hJUCVy9IgsmeVU0AtRrsoCm4YUUwM_Iu5R2AIxJKd6Ss6qpecuhWZCntU8_6ejo5hh_eGsGuvET0uvg0E5-DNQHuhrm_xHplT9QE3p6ExDpGg-DsbjHMCW6dBNG2o3B-bjHnq6i6TPtLyHDv603y5nUPcQxeEs7E6PHmN6TN84MCT8833Py_XJ1310Vt3dfr7vlbWG5VFNhJNRWiLapUHKFrrdqq4ysa8nRcNaCciidsHUtrK1bJXslOGBjjWtgC46fk88n7iGOv46YJr33yeIwmIDjMWnWVpyxSgieo9UpauOYUkSnD9HvTfytGehZu97pWbuetWtQOmvPpU_P_OM2z_9f-ec5B76cAphXPubpOlmPwWLvY5ar-9G_xP8DwE6TvA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1923112443</pqid></control><display><type>article</type><title>Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers</title><source>Elsevier</source><creator>Tandon, Tarang ; Tadros, Baha J. ; Akehurst, Harold ; Avasthi, Adhish ; Hill, Richard ; Rao, Madhu</creator><creatorcontrib>Tandon, Tarang ; Tadros, Baha J. ; Akehurst, Harold ; Avasthi, Adhish ; Hill, Richard ; Rao, Madhu</creatorcontrib><description>Methicillin-resistant Staphylococcus aureus (MRSA) is globally endemic and is a leading cause of surgical site infection (SSI). The purpose of this study was to evaluate the incidence of SSI in MRSA carriers undergoing elective hip or knee arthroplasty, who had confirmed eradication and to compare it with incidence of SSI in non-MRSA carriers.
This is a retrospective analysis of 6613 patients who underwent elective total hip arthroplasty (THA; n = 3347) and total knee arthroplasty (TKA; n = 3266) at our institution. A cohort of patients who were preoperatively colonized with MRSA was identified. We compared the infection rates with non-MRSA carriers.
We had a colonization rate of 1.3% (83 patients). A total of 79 patients had confirmed eradication of carrier status before surgical intervention. Of these, 38 were THAs and 41 were TKAs. Five of 79 patients (6.32%; 95% confidence interval [CI]: 2.35%-14.79%) had “deep SSI” within 1 year of surgery. There were 2 MRSA infections in THAs (relative risk 4.46; 95% CI: 1.12-17.82). There were 2 MRSA and 1 methicillin-sensitive Staphylococcus aureus infections in TKAs (relative risk 5.61; 95% CI: 1.81-17.38). A significant statistical difference in infection rates from MRSA negative control group was noted, which had a deep sepsis rate of 1.17% in THAs and 1.3% in TKAs over the same period.
In spite of a selective treatment program for carriers and confirmed eradication, there is still a significantly increased risk of SSI in MRSA-colonized patients undergoing hip or knee arthroplasties.</description><identifier>ISSN: 0883-5403</identifier><identifier>EISSN: 1532-8406</identifier><identifier>DOI: 10.1016/j.arth.2017.06.036</identifier><identifier>PMID: 28739308</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Aged, 80 and over ; Anti-Bacterial Agents - administration & dosage ; Arthroplasty, Replacement, Hip - adverse effects ; Arthroplasty, Replacement, Knee - adverse effects ; Chlorhexidine - administration & dosage ; Disinfectants - administration & dosage ; Elective Surgical Procedures - adverse effects ; Female ; Humans ; Incidence ; infection ; Male ; Methicillin-Resistant Staphylococcus aureus ; Middle Aged ; MRSA ; Mupirocin - administration & dosage ; periprosthetic ; Retrospective Studies ; Risk ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - microbiology ; Staphylococcus aureus ; Surgical Wound Infection - epidemiology ; Surgical Wound Infection - microbiology ; Surgical Wound Infection - prevention & control ; total hip arthroplasty ; total knee arthroplasty ; United Kingdom - epidemiology</subject><ispartof>The Journal of arthroplasty, 2017-12, Vol.32 (12), p.3711-3717</ispartof><rights>2017 Elsevier Inc.</rights><rights>Copyright © 2017 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c356t-a507c44982e536efdc6b6a57753ea31906fe5f4c774cc7965d6430e8caf80b0f3</citedby><cites>FETCH-LOGICAL-c356t-a507c44982e536efdc6b6a57753ea31906fe5f4c774cc7965d6430e8caf80b0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28739308$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tandon, Tarang</creatorcontrib><creatorcontrib>Tadros, Baha J.</creatorcontrib><creatorcontrib>Akehurst, Harold</creatorcontrib><creatorcontrib>Avasthi, Adhish</creatorcontrib><creatorcontrib>Hill, Richard</creatorcontrib><creatorcontrib>Rao, Madhu</creatorcontrib><title>Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers</title><title>The Journal of arthroplasty</title><addtitle>J Arthroplasty</addtitle><description>Methicillin-resistant Staphylococcus aureus (MRSA) is globally endemic and is a leading cause of surgical site infection (SSI). The purpose of this study was to evaluate the incidence of SSI in MRSA carriers undergoing elective hip or knee arthroplasty, who had confirmed eradication and to compare it with incidence of SSI in non-MRSA carriers.
This is a retrospective analysis of 6613 patients who underwent elective total hip arthroplasty (THA; n = 3347) and total knee arthroplasty (TKA; n = 3266) at our institution. A cohort of patients who were preoperatively colonized with MRSA was identified. We compared the infection rates with non-MRSA carriers.
We had a colonization rate of 1.3% (83 patients). A total of 79 patients had confirmed eradication of carrier status before surgical intervention. Of these, 38 were THAs and 41 were TKAs. Five of 79 patients (6.32%; 95% confidence interval [CI]: 2.35%-14.79%) had “deep SSI” within 1 year of surgery. There were 2 MRSA infections in THAs (relative risk 4.46; 95% CI: 1.12-17.82). There were 2 MRSA and 1 methicillin-sensitive Staphylococcus aureus infections in TKAs (relative risk 5.61; 95% CI: 1.81-17.38). A significant statistical difference in infection rates from MRSA negative control group was noted, which had a deep sepsis rate of 1.17% in THAs and 1.3% in TKAs over the same period.
In spite of a selective treatment program for carriers and confirmed eradication, there is still a significantly increased risk of SSI in MRSA-colonized patients undergoing hip or knee arthroplasties.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anti-Bacterial Agents - administration & dosage</subject><subject>Arthroplasty, Replacement, Hip - adverse effects</subject><subject>Arthroplasty, Replacement, Knee - adverse effects</subject><subject>Chlorhexidine - administration & dosage</subject><subject>Disinfectants - administration & dosage</subject><subject>Elective Surgical Procedures - adverse effects</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>infection</subject><subject>Male</subject><subject>Methicillin-Resistant Staphylococcus aureus</subject><subject>Middle Aged</subject><subject>MRSA</subject><subject>Mupirocin - administration & dosage</subject><subject>periprosthetic</subject><subject>Retrospective Studies</subject><subject>Risk</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - microbiology</subject><subject>Staphylococcus aureus</subject><subject>Surgical Wound Infection - epidemiology</subject><subject>Surgical Wound Infection - microbiology</subject><subject>Surgical Wound Infection - prevention & control</subject><subject>total hip arthroplasty</subject><subject>total knee arthroplasty</subject><subject>United Kingdom - epidemiology</subject><issn>0883-5403</issn><issn>1532-8406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp9kE1v1DAURS0EokPhD7BAXrJJ-hx_JJHYjKIprVpUaaasLY_zTD1knMHOVGLR_47DFJZdvbe490j3EPKRQcmAqYtdaeL0UFbA6hJUCVy9IgsmeVU0AtRrsoCm4YUUwM_Iu5R2AIxJKd6Ss6qpecuhWZCntU8_6ejo5hh_eGsGuvET0uvg0E5-DNQHuhrm_xHplT9QE3p6ExDpGg-DsbjHMCW6dBNG2o3B-bjHnq6i6TPtLyHDv603y5nUPcQxeEs7E6PHmN6TN84MCT8833Py_XJ1310Vt3dfr7vlbWG5VFNhJNRWiLapUHKFrrdqq4ysa8nRcNaCciidsHUtrK1bJXslOGBjjWtgC46fk88n7iGOv46YJr33yeIwmIDjMWnWVpyxSgieo9UpauOYUkSnD9HvTfytGehZu97pWbuetWtQOmvPpU_P_OM2z_9f-ec5B76cAphXPubpOlmPwWLvY5ar-9G_xP8DwE6TvA</recordid><startdate>201712</startdate><enddate>201712</enddate><creator>Tandon, Tarang</creator><creator>Tadros, Baha J.</creator><creator>Akehurst, Harold</creator><creator>Avasthi, Adhish</creator><creator>Hill, Richard</creator><creator>Rao, Madhu</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201712</creationdate><title>Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers</title><author>Tandon, Tarang ; Tadros, Baha J. ; Akehurst, Harold ; Avasthi, Adhish ; Hill, Richard ; Rao, Madhu</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c356t-a507c44982e536efdc6b6a57753ea31906fe5f4c774cc7965d6430e8caf80b0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anti-Bacterial Agents - administration & dosage</topic><topic>Arthroplasty, Replacement, Hip - adverse effects</topic><topic>Arthroplasty, Replacement, Knee - adverse effects</topic><topic>Chlorhexidine - administration & dosage</topic><topic>Disinfectants - administration & dosage</topic><topic>Elective Surgical Procedures - adverse effects</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>infection</topic><topic>Male</topic><topic>Methicillin-Resistant Staphylococcus aureus</topic><topic>Middle Aged</topic><topic>MRSA</topic><topic>Mupirocin - administration & dosage</topic><topic>periprosthetic</topic><topic>Retrospective Studies</topic><topic>Risk</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - microbiology</topic><topic>Staphylococcus aureus</topic><topic>Surgical Wound Infection - epidemiology</topic><topic>Surgical Wound Infection - microbiology</topic><topic>Surgical Wound Infection - prevention & control</topic><topic>total hip arthroplasty</topic><topic>total knee arthroplasty</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tandon, Tarang</creatorcontrib><creatorcontrib>Tadros, Baha J.</creatorcontrib><creatorcontrib>Akehurst, Harold</creatorcontrib><creatorcontrib>Avasthi, Adhish</creatorcontrib><creatorcontrib>Hill, Richard</creatorcontrib><creatorcontrib>Rao, Madhu</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of arthroplasty</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tandon, Tarang</au><au>Tadros, Baha J.</au><au>Akehurst, Harold</au><au>Avasthi, Adhish</au><au>Hill, Richard</au><au>Rao, Madhu</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers</atitle><jtitle>The Journal of arthroplasty</jtitle><addtitle>J Arthroplasty</addtitle><date>2017-12</date><risdate>2017</risdate><volume>32</volume><issue>12</issue><spage>3711</spage><epage>3717</epage><pages>3711-3717</pages><issn>0883-5403</issn><eissn>1532-8406</eissn><abstract>Methicillin-resistant Staphylococcus aureus (MRSA) is globally endemic and is a leading cause of surgical site infection (SSI). The purpose of this study was to evaluate the incidence of SSI in MRSA carriers undergoing elective hip or knee arthroplasty, who had confirmed eradication and to compare it with incidence of SSI in non-MRSA carriers.
This is a retrospective analysis of 6613 patients who underwent elective total hip arthroplasty (THA; n = 3347) and total knee arthroplasty (TKA; n = 3266) at our institution. A cohort of patients who were preoperatively colonized with MRSA was identified. We compared the infection rates with non-MRSA carriers.
We had a colonization rate of 1.3% (83 patients). A total of 79 patients had confirmed eradication of carrier status before surgical intervention. Of these, 38 were THAs and 41 were TKAs. Five of 79 patients (6.32%; 95% confidence interval [CI]: 2.35%-14.79%) had “deep SSI” within 1 year of surgery. There were 2 MRSA infections in THAs (relative risk 4.46; 95% CI: 1.12-17.82). There were 2 MRSA and 1 methicillin-sensitive Staphylococcus aureus infections in TKAs (relative risk 5.61; 95% CI: 1.81-17.38). A significant statistical difference in infection rates from MRSA negative control group was noted, which had a deep sepsis rate of 1.17% in THAs and 1.3% in TKAs over the same period.
In spite of a selective treatment program for carriers and confirmed eradication, there is still a significantly increased risk of SSI in MRSA-colonized patients undergoing hip or knee arthroplasties.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28739308</pmid><doi>10.1016/j.arth.2017.06.036</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0883-5403 |
ispartof | The Journal of arthroplasty, 2017-12, Vol.32 (12), p.3711-3717 |
issn | 0883-5403 1532-8406 |
language | eng |
recordid | cdi_proquest_miscellaneous_1923112443 |
source | Elsevier |
subjects | Aged Aged, 80 and over Anti-Bacterial Agents - administration & dosage Arthroplasty, Replacement, Hip - adverse effects Arthroplasty, Replacement, Knee - adverse effects Chlorhexidine - administration & dosage Disinfectants - administration & dosage Elective Surgical Procedures - adverse effects Female Humans Incidence infection Male Methicillin-Resistant Staphylococcus aureus Middle Aged MRSA Mupirocin - administration & dosage periprosthetic Retrospective Studies Risk Staphylococcal Infections - drug therapy Staphylococcal Infections - epidemiology Staphylococcal Infections - microbiology Staphylococcus aureus Surgical Wound Infection - epidemiology Surgical Wound Infection - microbiology Surgical Wound Infection - prevention & control total hip arthroplasty total knee arthroplasty United Kingdom - epidemiology |
title | Risk of Surgical Site Infection in Elective Hip and Knee Replacements After Confirmed Eradication of MRSA in Chronic Carriers |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A52%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Risk%20of%20Surgical%20Site%20Infection%20in%20Elective%20Hip%20and%20Knee%20Replacements%20After%20Confirmed%20Eradication%20of%20MRSA%20in%20Chronic%20Carriers&rft.jtitle=The%20Journal%20of%20arthroplasty&rft.au=Tandon,%20Tarang&rft.date=2017-12&rft.volume=32&rft.issue=12&rft.spage=3711&rft.epage=3717&rft.pages=3711-3717&rft.issn=0883-5403&rft.eissn=1532-8406&rft_id=info:doi/10.1016/j.arth.2017.06.036&rft_dat=%3Cproquest_cross%3E1923112443%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c356t-a507c44982e536efdc6b6a57753ea31906fe5f4c774cc7965d6430e8caf80b0f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1923112443&rft_id=info:pmid/28739308&rfr_iscdi=true |